SMARCB1 Antibody

Additional Information:
|Introduction SMARCB1(SWI/SNF-related matrix-assoc actin-dependent regulator of chromatin subfamily B member 1), also known as SNF5, INI1 or MALIGNANT RHABDOID TUMOR SUPPRESSOR, is a protein that in humans is encoded by the SMARCB1 gene. The SMARCB1 gene encodes a subunit of the SWI/SNF ATP-dependent chromatin-remodeling complex. The SMARCB1 gene maps to chromosome 22q11.2 (Versteege et al., 1998). Wu et al. (2002) noted that GADD34 (PPP1R15A) and SNF5 can coexist in a trimeric complex with chimeric leukemic HRX (MLL) fusion proteins, leading to inhibition of GADD34-med apoptosis. By mutation analysis, they showed that the GADD34 region homologous to the HSV-1 ICP34.5 protein was necessary for interaction with SNF5. SNF5 could bind independently with the protein phosphatase-1 (PP1) catalytic subunit (PPP1CA) and stimulate its activity in solution and in complex with GADD34. SNF5 and PP1 did not compete for GADD34 binding, but rather formed a stable trimeric complex with GADD34. Wu et al. (2002) proposed that GADD34 med growth suppression, at least in |A synthetic peptide corresponding to a sequence at the C-terminal of human SMARCB1, identical to the related rat and mouse sequences. Purification: Immunogen affinity purified. Applications: WB 0.1-0.5 ug/ml. Form of Antibody: Lyophilized. Reconstitution: 0.2 ml of distilled water will yield a concentration of 500 ug/ml. Storage/Stability: Stable for 1 year at -20°C and 3 months at 4°C. For maximum recovery of the product, centrifuge the original v after thawing and before removing the cap. Aliquot to avoid repeated freezing and thawing.